Market Overview

Health Canada Issues Medical Device License to ivWatch

Share:

Surveillance Monitoring to Advance IV Therapy Care Now Available in
Canada

ivWatch,
the only provider of continuous monitoring devices for the early
detection of intravenous (IV) infiltrations and extravasations, was
recently issued a medical device license (MDL) by Health Canada
permitting the company to sell the ivWatch
Model 400
to Canadian health care organizations.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180802005092/en/

ivWatch was issued a medical device license (MDL) by Health Canada permitting the company to sell th ...

ivWatch was issued a medical device license (MDL) by Health Canada permitting the company to sell the ivWatch Model 400 to Canadian health care organizations. (Photo: Business Wire)

"This is yet another milestone allowing more medical care providers and
patients access to a first-of-its-kind technology to minimize harm from
peripheral IV infiltration/extravasation events (PIVIEs)," said Scott
Hensley, vice president of sales and business development at ivWatch.
"Canada is one of the most progressive health care markets in the world
and acknowledge PIVIEs as serious safety events. Clinicians understand
the need for surveillance monitoring to improve patient safety."

Every infiltration is a medication dosing and delivery error that can
impact the patient through prolonged hospital stays, temporary harm or
permanent injuries. Beyond the patient safety impact, any of these
adverse events may result in increased expenses, significant legal risk
and reputation damage for health care providers and facilities.

"We're excited to work with health systems and pediatric hospitals who
have quality improvement measures in place and stand ready to implement
technology capable of drastically reducing the time to detect a PIVIE
beyond what is currently possible by visual and tactile assessment,"
said Hensley.

The MDL is the final step for Canadian market entry and was preceded by
the company's
achievement of ISO 13485 Certification
, the global standard for
medical device quality management systems (QMS) developed by the
International Organization for Standardization (ISO®).

To learn more about ivWatch and the Model 400, visit www.ivWatch.com.

About ivWatch:

ivWatch,
LLC
 is the leading medical device manufacturer and biosensor
technology company focused on improving patient safety and the
effectiveness of intravenous therapy. Our dedicated and passionate team
is focused on our company vision of eliminating patient harm caused by
infiltrations and extravasations. Through our innovative monitored IV
solutions, we help minimize the risks associated with adverse IV events.
Follow us on Twitter @ivWatch or
Facebook @ivWatchLLChttps://www.ivwatch.com/

View Comments and Join the Discussion!